As Sanofi's Pompe drug shortage drags on, some patients struggle to access treatments
CNBC
An ongoing shortage of Sanofi’s Pompe disease treatment is forcing some patients to miss critical doses. They worry their health is at risk.
Read the full story
This is a short summary. The complete article is published by CNBC.
Headline and summary aggregated from public news feeds. For information only — not financial advice.